Ardelyx is a publicly traded commercial biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been approved in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. Position Summary: We are seeking a Scientist, Preclinical Operations to join our experienced drug discovery and development team and help advance our gastrointestinal (GI) and cardiorenal research programs. The successful candidate will contribute to the development of GI/cardiorenal translational and biomarker strategies and provide scientific support across multiple drug programs. A key component of this role will be coordinating and monitoring work conducted by contract research organizations (CROs), with a focus on evaluating drug targets and mechanisms involved in GI and cardiorenal pathophysiology in support of the company’s discovery and development efforts.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Education Level
Ph.D. or professional degree
Number of Employees
251-500 employees